TNF-α/OX40L bispecific antibody shows efficacy in models of rheumatoid arthritis
Nov. 28, 2023
Researchers from Seoul National University presented results of preclinical evaluation of a new TNF-α/OX40L bispecific antibody, IMB-101, being developed for the treatment of rheumatoid arthritis (RA).